hello all, i saw someone posted during the w/e that total scripts were 6215 (if i recall well) for last week, but could someone (Frenzy ? Cincy ?) pls provide the breakdown between new & refills ?
many thx in advance, best, AC
I think the 6215 is the number this week. I never would have dreamed the share price would have ever hit under two dollars even with Anchor but if Rx dose not improve dramatically soon there will be little on no improvement in share price. Another down week in Rx will drive the share privde down quickly. There are no other catalysts left to drive share price now other than Rx numbers which have been very weak after an entire year of promotion. 5% share spells no success in converting patients from Lovaza to Vascepa. Even GSK probably expected much more conversion than these guys have accomplished. It has obviously been an absolutely pitiful marketing job by Amarin. Success in the pharmaceutical business is measured by the ability to influence physician prescribing habits. At 5% share after an entire year Amarin has been a total failure at achieving this. But when it comes to Amarin it does not surprise because they fail to deliver on virtually everything.
To hear JZ say he was disappointed in Vascepa Rx uptake Wednesday night was a huge red flag. Moreover, after a blow like this it will be VERY hard to focus the sales team on being productive in what is a low productivity job anyway.